Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules used to ...

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

An upcoming clinical trial will test whether empagliflozin might be able to improve heart health in pulmonary arterial ...

Authors randomly allocated 1,385 participants to four groups --- 551 to GMRx2, 276 to telmisartan–indapamide, 282 to telmisartan–amlodipine, and 276 to amlodipine–indapamide groups ...

Alembic Pharmaceuticals has received final USFDA approval for its Diltiazem Hydrochloride Extended-Release Capsules, used for ...

Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2 ...

The ASA has published the first updated guideline for primary stroke prevention in 10 years. Its recommendations align with ...

Nathan Radcliffe, MD, shared insights from his presentation at the annual meeting of the American Academy of Ophthalmology ...

Diltiazem Hydrochloride is prescribed to treat hypertension (high blood pressure) and chronic stable angina (chest pain).

These medications are widely prescribed to manage high blood pressure and prevent heart-related issues like heart attacks, ...

According to the British Heart Foundation, more than 12.5 million adults in the UK are currently living with high blood ...

Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride ...